Elizabeth McKenna

@ElizSMcKenna

Executive Editor of Cancer Discovery , published by . / alum. Native New Yorker. Tweets are my own.

Philadelphia, PA
Vrijeme pridruživanja: ožujak 2009.

Tweetovi

Blokirali ste korisnika/cu @ElizSMcKenna

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ElizSMcKenna

  1. Prikvačeni tweet
    28. lis 2019.

    Just published in to coincide with the highly anticipated presentation at : The Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of Mutant Cancers in Mouse Models and Patients

    Poništi
  2. proslijedio/la je Tweet
    prije 3 sata

    Our discussion of the very nice paper on the role of pyroptosis and the immune system in targeted therapy responses in melanoma by in is online now!

    Poništi
  3. proslijedio/la je Tweet

    In a study funded by , researchers showed that circulating tumor cells () from patients with breast cancer recapitulate patterns of in mice and reveal drivers of metastatic growth in the brain .

    Poništi
  4. proslijedio/la je Tweet

    Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction | Cancer Discovery

    Poništi
  5. proslijedio/la je Tweet
    1. velj

    Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction | Cancer Discovery ⁦ |

    Poništi
  6. proslijedio/la je Tweet
    prije 17 sati

    Great review on the current therapeutic landscape in AML!

    Poništi
  7. proslijedio/la je Tweet

    Great review and looking forward to hosting on March 23rd . A seminar not to be missed (Bluemle Life Sciences Building, noon)!!!

    Poništi
  8. proslijedio/la je Tweet
    4. velj

    Great review on fibroblast heterogeneity in Pancreatic cancer by !!

    Poništi
  9. Had a fantastic time visiting - thank you all for your gracious hospitality, especially for hosting and for making sure everything went smoothly. Hope to see you all again soon!

    Poništi
  10. proslijedio/la je Tweet

    Advances in the Treatment of Acute Myeloid : New Drugs and New Challenges | via | , Konopleva, , , Ravandi, DiNardo, and of .

    Poništi
  11. proslijedio/la je Tweet

    Very proud of this review on novel AML therapeutics now published in !

    Poništi
  12. proslijedio/la je Tweet
    prije 21 sat

    , executive editor, joins us to talk to about !

    Poništi
  13. Thank you so much for hosting me!! I had a wonderful visit!!

    Poništi
  14. proslijedio/la je Tweet
    2. velj

    Congrats! FADD and death receptor signaling came up also in our screens: . et al dig deeper into this to show how leukemia cells resistant to death receptor apoptosis induce dysfunction in CAR T cells, explaining primary resistance

    Poništi
  15. proslijedio/la je Tweet

    Pediatric cancer survivorship portal released. “We want to make this data accessible to as many types of scientific researchers & clinicians as possible." -Dr. Alex Gout, lead scientist of the St. Jude Cloud project.

    Poništi
  16. proslijedio/la je Tweet
    3. velj

    From the January issue: The inhibitor MRTX849 provides insight into therapeutic susceptibility of -mutant cancers in mouse models and patients.

    Poništi
  17. proslijedio/la je Tweet
    3. velj

    From the January issue: The first-in-human of -pathway blockade for cancer

    Poništi
  18. 3. velj

    Very excited to share this important review in by synthesizing all the recent discoveries on CAF heterogeneity in !

    Poništi
  19. proslijedio/la je Tweet
    3. velj

    This is an important invited commentary from in on a “grand unification” strategy for all of the recently reported CAF heterogeneity studies in

    Poništi
  20. 3. velj

    State unlocked: Michigan - excited for my visit to !

    Poništi
  21. proslijedio/la je Tweet
    3. velj

    Associate Editor is at - be sure to say hello!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·